HLA-DPA1*0202 & HLA-DPB1*0301 & KRAS (TEYKLVVVGAVGV)

HLA-DPA1*0202 & HLA-DPB1*0301 & KRAS (TEYKLVVVGAVGV)

Produktanfrage

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
UB-621UB-621Phase 2 ClinicalUnited Biopharma Inc
Herpes Simplex; Herpes Genitalis
Details
Customer Reviews